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Abstract
Background: Over the centuries, opium has been the most frequent substance abused in the
Middle East. There are many controversial aspects about the effects of opioids on the
atherosclerosis process, which is still unclear.
Methods: All patients who were candidates for coronary artery bypass graft in Tehran Heart
Center were registered and evaluated for risk factors such as diabetes mellitus, hypertension,
smoking status and duration, opium abuse, involved coronary arteries and left main branch
lesion > 50%, carotid stenosis ≥ 70%.
Results: A total of 1,339 patients were enrolled in the study, of whom 400 (29.9%) were
female and the other 939  (70.1%) male. Female patients were omitted from analysis due to the
low numbers of female opium addicts. Our study revealed that in the addicted population, the
risk of diabetes and hypertension was lower than in the non-addicted group (p < 0.05 for each
variable) and fasting blood sugar tended to be less in addicted ones, but the number of involved
coronary arteries, left main stenosis > 50% and extent of carotid stenosis was not significantly
different between the two groups.
Conclusions: Our investigations demonstrate that opium is not cardioprotective, as has been
claimed by some previous studies, and does not even decelerate atherosclerosis of carotid
arteries in opium-addicted patients, but more evidence is still needed to completely prove the
case. (Cardiol J 2010; 17, 3: 254–258)
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Introduction
Opium dependence is one of the major health
problems in the developing countries of the Mid-
dle East, and particularly our country Iran. Over
many decades, opium has been the substance most
frequently abused in Iran. Opium, in contrast to pure
opioid drugs, is a complex and variable mixture of
substances. It is reported that between 1 and 30 g
of opium may be used by an addict, either orally or
inhaled.
More than 180 million people around the world
have tried illegal drugs at least once, of whom
13.5 million are opium-dependent [1]. The effects
of opium are essentially those of morphine. The ma-
jor effects of opium are on the central and autonomic
nervous system and the bowels, while it also influ-
ences other organ systems including the respira-
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tory and cardiovascular systems [1]. Orthostatic
hypotension has been reported after opium con-
sumption. Several investigations about the effects
of opioid peptides on the cardiovascular system
have also been performed. They show that hypoten-
sion, bradycardia, peripheral vasodilatation (or
sometimes hypotension and tachycardia) are among
the cardiovascular effects of opioids [2, 3] which
proceed mainly through their effects on K and Ca
channels as well as adenylate cyclase [4, 5]. It is
estimated that the prevalence of opium addiction
has grown three fold in the past 20 years in Iran;
now it is thought to be 2–2.8%, according to official
figures [6–8]. Numerous studies have shown the
effects of opium on the cardiovascular system, but
few studies have focused on its distinct effect on
carotid artery stenosis or the number of carotid
plaques. A study of Iranian drivers showed signifi-
cantly lower cholesterol levels, as well as lower
diastolic blood pressure, which in combination with
other effects of opium can influence the outcome
of cardiovascular disease [9–12].
Considering this data, we decided to perform
this study to evaluate the probable effects of opium
on the vascular system. The aim of the present study
was to determine opium consumption as a risk fac-
tor for carotid artery stenosis and its influence on
the number of atheromatous plaques, and to compare
the characteristics of opium addicts to non-addicts.
Methods
From January 2006 to January 2007, all patients
who were candidates for coronary artery bypass
graft (CABG) in Tehran Heart Center were regis-
tered. Patients were examined by hospital cardiol-
ogists and heart surgeons, and a complete history
was taken to reveal cardiovascular risk factors such
as diabetes mellitus, hypertension, smoking status
and duration. Patients who fulfilled the DSM-IV-TR
criteria for substance (opium) dependence (by
smoking or oral intake) were enrolled as opium
dependent patients. Meanwhile, the data from pa-
tients’ coronary angiography report (the number of
involved coronary arteries and left main branch le-
sion > 50%) were also added to our data. All CABG
candidates underwent a Doppler sonography of both
carotid arteries to detect any atheromatous plaque
and stenosis prior to surgery. This completed the
set of our data. The definitions of cardiovascular risk
factors were those set out by the Society of Tho-
racic Surgeons of America. Degrees to define ca-
rotid stenosis were based on the NASCET criteria.
Due to the very low percentage of opium depen-
dence in our female patients, they were excluded
from the study except in primary analysis about
demographic report and frequency of risk factors.
Our study was approved by the medical ethics
committee of the Hospital and University of Tehran,
and the Faculty of Medicine.
Statistical analysis
For continuous variables including age and con-
sumption of opium per day, the values are expressed
as mean ± standard deviation. For discrete variables,
values are expressed as percentages. For continu-
ous variables t-test was used to access the difference
between the two groups. For qualitative variables,
chi- square test was used. For small sizes we used
Fisher’s exact test. All statistical analyses were per-
formed using SPSS for Windows ver. 13.
Results
A total of 1,339 patients were enrolled in this
study of whom 400 (29.9%) were female and 939
(70.1%) male. The characteristics of risk factors in our
patients are shown in Table 1.
The next step was to analyze the probable dif-
ferences between addicts and non-addicts. Demo-
graphic data revealed that there was a significant dif-
ference (p < 0.05) between the mean age of opium
dependent and non-dependent patients (55.8 ± 9.2 vs
59.2 ± 9.5). As we mentioned earlier in Table 1, there
was a marked difference between addicted male and
female patients. Male patients tended to use opioids
more than female ones (p < 0.05). Comparing body
mass index between the two groups, we realized that
opium addicts were significantly slimmer than non-
addicts (26.4 ± 3.45 vs 59.2 ± 9.5).
In the addict group, the incidence of diabetes
and hypertension was markedly less than in the
non- addicted group. Involved coronary arteries and
left main branch stenosis > 50% was not signifi-
cant between two groups. Post-operative mortali-
ty did not show significant differences between the
two groups. The number of involved coronary ar-
teries, left main stenosis > 50% and carotid steno-
sis at each side were not significantly different be-
tween the two groups. The addicted group had both
more pack years and duration of smoking than the
non-addicted group (p = 0.01). Surprisingly, we did
not find any notable difference between the serum
level of lipid profile (triglycerides, cholesterol, HDL
and LDL) of opium-addicted and non-opium addict-
ed patients. Further analysis showed that opium
consumption cannot be assumed to be a risk factor
for significant carotid stenosis (≥ 70%). Fasting
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blood sugar was significantly less in the addicted
population (p = 0.02). Moreover, we detected that
HbA1c was markedly less in the addict group (p =
= 0.03). Serum level of CRP was also higher in ad-
dicted patients (p = 0.04; Table 2).
Discussion
The word opium is derived from the Greek
name for juice, the drug being obtained from the
juice of the poppy, papaver somniferum [13]. Ac-
cording to official reports, the prevalence of opium
addicts is 2–2.8% in Iran [6–8]. But our study indi-
cated that 12.6% of all (and 15.7% of our male) pa-
tients use opium, which tends to be much more than
official reports. There are beliefs about the protec-
tive effect of opium.
In Middle Eastern countries, opium consump-
tion has traditionally been regarded as a way to low-
er blood lipids and thus prevent cardiovascular dis-
eases, which could ultimately lead to addiction.
Even some scientific studies have proved that opi-
um use may have a cardioprotective effect [14–16].
Schulz and Gross [14] found numerous recep-
tors for opium in the hearts of large animal mod-
els. They believed that opioids decrease the pain
after myocardial infarction as well as infarct size,
and so could be cardioprotective. Our study showed
no evidence for an association between atheroscle-
rosis in carotid and coronary arteries and opium
usage, which does not support the notion of car-
dioprotectiveness of opioids. However, other re-
searchers assume opioids to be an aggravating fac-
tor, or even a probable risk factor, for cardiovas-
cular diseases [17]. The theory of atherogenic ef-
fects of opioids offered by Mohammadi et al. [17]
claimed that opium use can increase serum levels
of lipids that ends up as atheroma formation in the
aorta of addicted rats.
They also found out an association between the
duration of addiction and increase in serum level of
lipids. Asgary et al. [18] showed that there was
a direct correlation between opioids blood levels and
duration of addiction. In their study, they also not-
ed that the levels of HbA1c, C-reactive protein, fac-
tor VII, Fibrinogen, apo B, Lpa, SGOT, and SGPT
were significantly higher in the case subjects as
compared with controls, and that HDL-cholesterol
and apo-a were significantly lower in the case sub-
jects, That would mean that opium acts as a cardio-
vascular disease risk factor. In contrast, our find-
ings support the fact that the lipid profile of addict-
ed and non-addicted people does not differ. This has
been claimed previously by other researches [19,
20]. In short, there is no definite answer regarding
the cardiovascular effects of opium consumption.
Opium dependents were at the same time ciga-
rette smokers (65.5%), as we had predicted. This
is no surprise because most opium dependent pa-
tients are smokers as well. However, in the
smoker category, a significant difference was ob-
served between opium users and non-users in
the pattern of three vessel disease distribution,
but not enough to prove that opioids have pro-
tecting vascular effects. As we mentioned earli-
er, the mean age of opium addicts was markedly
Table 1. Patient characteristics between female and male group.
Female Male P
Age 60.8 ± 8.5 58.7 ± 9.7 0.001
Opium addiction No addiction: 98.5% No addiction: 84.3% 0.001
< 10 years: 0.5% < 10 years: 7.8% 0.001
≥ 10 years: 0.1% ≥ 10 years: 7.9% 0.001
Hypertension 68.6% 46.5% 0.00
Diabetes 61.7% 27.8% 0.00
Smoking 10.5% 48.1% 0.00
Right carotid stenosis ≥ 70% 1.1% 1.5% NS*
Left carotid stenosis ≥ 70% 1% 0.8% NS
Carotid stenosis ≥ 70% any side 1.8 2.2% NS
Involved coronary arteries
1 vessel disease 9% 4.4% NS
2 vessel disease 20.2% 20.1% NS
3 vessel disease 70.8% 75.5% NS
Left main lesion > 50% 12.2% 13.8% NS
*NS — not significant
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lower than non-dependents. This may be an ex-
planation for the matter above. Some studies [9–
–12, 19, 20] suggest that opium addicts have a low-
er cholesterol level diastolic blood pressure than
the normal population. In our study, we did not
detect significant changes between serum levels
of lipids between two groups. Hence, the effect
of opioids on the cardiovascular system is still un-
clear and controversial. Further larger scale stud-
ies are needed to throw light on this subject.
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